当前位置:Public Access >页面
Chinese/English
The randomized,controlled,multicenter clinical stduy of Xiaoyan Granule combined with Apatinib Mesylas in the treatment of advanced non-small cell lung cancer patients
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。